Pascal Ellerbrock

Affiliations

Pharmaceuticals, Research and Development, Bayer AG, 42133 Wuppertal, Germany.

Publications (1)

Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders.

Journal of medicinal chemistry

Avec: Susanne Roehrig , Jens Ackerstaff , Eloísa Jiménez Núñez , Henrik Teller , Pascal Ellerbrock , Katharina Meier , Stefan Heitmeier , Adrian Tersteegen , Jan Stampfuss , Dieter Lang , Karl-Heinz Schlemmer , Martina Schaefer , Kersten M Gericke , Tom Kinzel , Daniel Meibom , Martina Schmidt , Christoph Gerdes , Markus Follmann , Alexander Hillisch

Réseau de co-auteurs

Susanne Roehrig 1 collaboration

Jens Ackerstaff 1 collaboration

Eloísa Jiménez Núñez 1 collaboration

Henrik Teller 1 collaboration

Katharina Meier 1 collaboration

Stefan Heitmeier 1 collaboration

Adrian Tersteegen 1 collaboration

Jan Stampfuss 1 collaboration

Dieter Lang 1 collaboration

Karl-Heinz Schlemmer 1 collaboration

Martina Schaefer 1 collaboration

Kersten M Gericke 1 collaboration

Tom Kinzel 1 collaboration

Daniel Meibom 1 collaboration

Martina Schmidt 1 collaboration

Christoph Gerdes 1 collaboration

Markus Follmann 1 collaboration

Alexander Hillisch 1 collaboration